Revance Therapeutics reported $-70337000 in Operating Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbvie ABBV:US $ 4441M 338M
Adamas Pharmaceuticals ADMS:US -9155000 370K
Aerie Pharmaceuticals AERI:US $ -31.5M 2.72M
ALKERMES ALKS:US 4.42M 22.95M
Antares Pharma ATRS:US $ 6.79M 1.4M
Biodelivery Sciences International BDSI:US $ 15.66M 8.22M
Bristol Myers Squibb BMY:US $ 1715M 36M
Cara Therapeutics CARA:US $ -30876000 7.32M
Coherus Biosciences CHRS:US $ -24.16M 143.2M
Eli Lilly And LLY:US $ 1403.4M 248.1M
Endo International Ordinary Shares ENDP:US $ 143.1M 39.58M
Flexion Therapeutics FLXN:US $ -16882000 6.26M
Gw Pharmaceuticals GWPH:US $ -21.03M 1.78M
Horizon Pharma HZNP:US $ 138.51M 298.53M
JAZZ PHA JAZZ:US $ -69.59M 231.71M
Johnson & Johnson JNJ:US $ 3849M 2813M
Merk MRK:US $ 1497M 1517M
Neurocrine Biosciences NBIX:US $ 62.8M 31.3M
Pacira Pharmaceuticals PCRX:US $ 34.84M 15.41M
Procter & Gamble PG:US $ 5023M 1483M
Revance Therapeutics RVNC:US $ -70337000 325K
Supernus Pharmaceuticals SUPN:US $ 34.11M 20.9M
Teva Pharmaceutical Industries TEVA:US $ 582M 148M
Zogenix ZGNX:US $ -55.43M 3.63M